WallStSmart

Nomura Holdings Inc ADR (NMR)vsStonex Group Inc (SNEX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 1340% more annual revenue ($2.17T vs $150.54B). NMR leads profitability with a 16.7% profit margin vs 0.3%. NMR trades at a lower P/E of 13.5x. NMR earns a higher WallStSmart Score of 70/100 (B-).

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.0Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

SNEX

Buy

60

out of 100

Grade: C+

Growth: 9.3Profit: 5.0Value: 5.3Quality: 4.0
Piotroski: 1/9Altman Z: 3.49

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR4 strengths · Avg: 8.5/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

SNEX5 strengths · Avg: 8.8/10
EPS GrowthGrowth
120.2%10/10

Earnings expanding 120.2% YoY

Altman Z-ScoreHealth
3.4910/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
23.8%8/10

Revenue surging 23.8% year-over-year

Free Cash FlowQuality
$4.19B8/10

Generating 4.2B in free cash flow

Areas to Watch

NMR3 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.1%4/10

4.1% earnings growth

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

SNEX4 concerns · Avg: 2.5/10
Profit MarginProfitability
0.3%3/10

0.3% margin — thin

Operating MarginProfitability
0.5%3/10

Operating margin of 0.5%

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Debt/EquityHealth
7.161/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, PEG Ratio, P/E Ratio. Profitability is solid with margins at 16.7% and operating margin at 19.5%. Revenue growth of 27.5% demonstrates continued momentum.

Bull Case : SNEX

The strongest argument for SNEX centers on EPS Growth, Altman Z-Score, Price/Book. Revenue growth of 23.8% demonstrates continued momentum.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Altman Z-Score, Debt/Equity. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Bear Case : SNEX

The primary concerns for SNEX are Profit Margin, Operating Margin, Piotroski F-Score. Debt-to-equity of 7.16 is elevated, increasing financial risk. Thin 0.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

SNEX carries more volatility with a beta of 0.66 — expect wider price swings.

NMR is growing revenue faster at 27.5% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 60/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Stonex Group Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

StoneX Group Inc. is a global financial services network connecting businesses, organizations, merchants and investors to the global market ecosystem. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?